March 23, 2023

Advertising Law News and Analysis

1 min

In AWAREmed Settlement FTC Says Opioid and Chronic Disease Ad Claims Must Be Backed by Science

The Federal Trade Commission's recent settlement with Dalal A. Akoury and AWAREmed Health & Wellness Resource Center provides a good overview of how today's FTC approaches medical claims it believes are unsubstantiated. The case also serves as a reminder that if medical claims sound too good to be true, they probably are.

New York AG Proposes New Price Gouging Rules

Earlier this month, New York Attorney General Letitia James issued a Notice of Proposed Rulemaking aimed at setting greater guardrails against price increases during emergencies. The action comes exactly one year after James first initiated the rulemaking process by seeking comment regarding potential price gouging during the COVID-19 pandemic.

The National Advertising Division Recommends That Pier 1 Modify Subscription Disclosures

Last month, the National Advertising Division of BBB National Programs reviewed Pier 1's subscription rewards program and recommended that the company provide clearer disclosures of the automatic renewal program.

Communications Industry News

Check out the inaugural edition of Venable's Communications Industry News. This monthly newsletter will feature insights from our Communications Practice Group on the latest issues affecting the wireless, telecommunications and space industries.

Subscribe to receive our Advertising Law News and Analysis newsletter and invitations to upcoming events.